Adalimumab in active ulcerative colitis: a "real-life" observational study

Alessandro Armuzzi, Luisa Guidi, Livia Biancone, Marco Daperno, Alessandra Coli, Vito Annese, Annalisa Aratari, Sandro Ardizzone, Paola Balestrieri, Fabrizio Bossa, Maria Cappello, Fabiana Castiglione, Michele Cicala, Silvio Danese, Renata D'Incà, Pietro Dulbecco, Giuseppe Feliciangeli, Walter Fries, Stefania Genise, Paolo GionchettiStefano Gozzi, Anna Kohn, Roberto Lorenzetti, Monica Milla, Sara Onali, Ambrogio Orlando, Luigi Giovanni Papparella, Sara Renna, Chiara Ricci, Fernando Rizzello, Raffaello Sostegni, Claudio Papi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

55 Citazioni (Scopus)

Abstract

The effectiveness of adalimumab in the treatment of ulcerative colitis is under debate. Although controlled trials have shown that adalimumab is significantly better than placebo, the absolute clinical benefit is modest. We report data on the effectiveness of adalimumab in a cohort of ulcerative colitis patients treated in 22 Italian centres.
Lingua originaleEnglish
pagine (da-a)738-743
Numero di pagine6
RivistaDIGESTIVE AND LIVER DISEASE
Volume45
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • Adalimumab
  • Ulcerative colitis
  • “Real-life” study

Fingerprint Entra nei temi di ricerca di 'Adalimumab in active ulcerative colitis: a "real-life" observational study'. Insieme formano una fingerprint unica.

Cita questo